Alterity Therapeutics (ATHE) Cash from Financing Activities (2016 - 2019)

Alterity Therapeutics' Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $166760.3 for Q4 2019.

• In Q4 2019, Cash from Financing Activities rose 62.62% year-over-year to $166760.3; the TTM figure through Dec 2019 stood at $124416.7 (changed N/A YoY), while the FY2025 annual figure was $25.4 million, up 318.28% from the prior year.
• Cash from Financing Activities was $166760.3 for Q4 2019 at Alterity Therapeutics, up from $102549.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $166760.3 in Q4 2019 to a low of -$115796.0 in Q4 2016.
• Historically, Cash from Financing Activities has averaged $31104.2 across 4 years, with a median of $36726.2 in 2017.
• The sharpest annual moves came in 2018 and 2019: Cash from Financing Activities jumped 452.44% in 2018, then surged 62.62% in 2019.
• A 4-year view of Cash from Financing Activities shows it stood at -$115796.0 in 2016, then surged by 74.87% to -$29096.6 in 2017, then surged by 452.44% to $102549.0 in 2018, then surged by 62.62% to $166760.3 in 2019.
• The last three Cash from Financing Activities figures came in at $166760.3 (Q4 2019), $102549.0 (Q4 2018), and -$29096.6 (Q4 2017), per Business Quant data.